Skip to main content
. 2008 Dec 5;191(5):1587–1594. doi: 10.1128/JB.01205-08

TABLE 1.

Effects of MfpAMt and QnrB4 on DNA gyrases

Type of effect Type II topoisomerase Effect of:
MfpAMt QnrB4
Direct effect on catalysis M. tuberculosis DNA gyrase Inhibition of supercoiling activity (IC50, 2 μM) No effect until 20 μM
E. coli DNA gyrase Inhibition of supercoiling activity (IC50, 3 μM) No effect until 30 μM
Protection from fluoroquinolone inhibition M. tuberculosis DNA gyrase No protection, no modification of ciprofloxacin or moxifloxacin IC50 No protection, no modification of ciprofloxacin IC50
E. coli DNA gyrase No protection, no modification of ciprofloxacin IC50 Concentration-dependent protective effect, increase of ciprofloxacin and moxifloxacin IC50s in the presence of QnrB4